These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 35435272)

  • 21. The effect of tocilizumab, anakinra and prednisolone on antibody response to SARS-CoV-2 in patients with COVID-19: A prospective cohort study with multivariate analysis of factors affecting the antibody response.
    Başaran S; Şimşek-Yavuz S; Meşe S; Çağatay A; Medetalibeyoğlu A; Öncül O; Özsüt H; Ağaçfidan A; Gül A; Eraksoy H
    Int J Infect Dis; 2021 Apr; 105():756-762. PubMed ID: 33737128
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of COVID-19 pneumonia with glucocorticoids (CORTIVID): a structured summary of a study protocol for a randomised controlled trial.
    Les Bujanda I; Loureiro-Amigo J; Bastons FC; Guerra IE; Sánchez JA; Murgadella-Sancho A; Rey RG; López JL; Álvarez JS
    Trials; 2021 Jan; 22(1):43. PubMed ID: 33430891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of Anakinra to Prevent Mechanical Ventilation in Severe COVID-19: A Case Series.
    Navarro-Millán I; Sattui SE; Lakhanpal A; Zisa D; Siegel CH; Crow MK
    Arthritis Rheumatol; 2020 Dec; 72(12):1990-1997. PubMed ID: 32602262
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Longitudinal changes in inflammatory biomarkers among patients with COVID-19: A nationwide study in Iceland.
    Oskarsdottir T; Sigurdsson MI; Palsson R; Eythorsson E
    Acta Anaesthesiol Scand; 2022 Sep; 66(8):969-977. PubMed ID: 35748857
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anakinra in hospitalized patients with severe COVID-19 pneumonia requiring oxygen therapy: Results of a prospective, open-label, interventional study.
    Balkhair A; Al-Zakwani I; Al Busaidi M; Al-Khirbash A; Al Mubaihsi S; BaTaher H; Al Aghbari J; Al Busaidi I; Al Kindi M; Baawain S; Al Alawi A; Al Lawati A; Al Rawahi B; Al-Baimani K; Al Zidi K; Elfatih N; Dawud B; John B; Rehman F; Yousif F; Al Khadouri G; Saber I; Lal J; Gargouri M; Al-Ward M; AbuDraz N; Al Ruqeishi S; Kumar S; Abdelmottaleb W; Al-Naamani Z; Bin Nazar Z; Balkhair O
    Int J Infect Dis; 2021 Feb; 103():288-296. PubMed ID: 33217576
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of anakinra in adults presenting deteriorating respiratory symptoms from COVID-19: A randomized controlled trial.
    Audemard-Verger A; Le Gouge A; Pestre V; Courjon J; Langlois V; Vareil MO; Devaux M; Bienvenu B; Leroy V; Goulabchand R; Colombain L; Bigot A; Guimard T; Douadi Y; Urbanski G; Faucher JF; Maulin L; Lioger B; Talarmin JP; Groh M; Emmerich J; Deriaz S; Ferreira-Maldent N; Cook AR; Lengellé C; Bourgoin H; Mekinian A; Aouba A; Maillot F; Caille A
    PLoS One; 2022; 17(8):e0269065. PubMed ID: 35925914
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CRP, SAA, LDH, and DD predict poor prognosis of coronavirus disease (COVID-19): a meta-analysis from 7739 patients.
    Wang L; Yang LM; Pei SF; Chong YZ; Guo Y; Gao XL; Tang QY; Li Y; Feng FM
    Scand J Clin Lab Invest; 2021 Dec; 81(8):679-686. PubMed ID: 34762008
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID): a factorial, randomised, controlled trial.
    Declercq J; Van Damme KFA; De Leeuw E; Maes B; Bosteels C; Tavernier SJ; De Buyser S; Colman R; Hites M; Verschelden G; Fivez T; Moerman F; Demedts IK; Dauby N; De Schryver N; Govaerts E; Vandecasteele SJ; Van Laethem J; Anguille S; van der Hilst J; Misset B; Slabbynck H; Wittebole X; Liénart F; Legrand C; Buyse M; Stevens D; Bauters F; Seys LJM; Aegerter H; Smole U; Bosteels V; Hoste L; Naesens L; Haerynck F; Vandekerckhove L; Depuydt P; van Braeckel E; Rottey S; Peene I; Van Der Straeten C; Hulstaert F; Lambrecht BN
    Lancet Respir Med; 2021 Dec; 9(12):1427-1438. PubMed ID: 34756178
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Importance of D-Dimer, Ferritin, CRP and Lymphocyte Values in Determining Mortality in COVID-19 Disease in Turkey.
    Topcu H; Arik YE
    Clin Lab; 2022 May; 68(5):. PubMed ID: 35536077
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The study of serum hsCRP, ferritin, IL-6 and plasma D-dimer in COVID-19: a retrospective study.
    Ahirwar AK; Takhelmayum R; Sakarde A; Rathod BD; Jha PK; Kumawat R; Gopal N
    Horm Mol Biol Clin Investig; 2022 Sep; 43(3):337-344. PubMed ID: 35357792
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Short term, high-dose vitamin D supplementation for COVID-19 disease: a randomised, placebo-controlled, study (SHADE study).
    Rastogi A; Bhansali A; Khare N; Suri V; Yaddanapudi N; Sachdeva N; Puri GD; Malhotra P
    Postgrad Med J; 2022 Feb; 98(1156):87-90. PubMed ID: 33184146
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anakinra as a potential treatment for COVID-19.
    McCarthy MW
    Drugs Today (Barc); 2023 Mar; 59(3):107-112. PubMed ID: 36847621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Basic Predictive Risk Factors for Cytokine Storms in COVID-19 Patients.
    Shcherbak SG; Anisenkova AY; Mosenko SV; Glotov OS; Chernov AN; Apalko SV; Urazov SP; Garbuzov EY; Khobotnikov DN; Klitsenko OA; Minina EM; Asaulenko ZP
    Front Immunol; 2021; 12():745515. PubMed ID: 34858403
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SARS-CoV-2 Viremia is Associated With Inflammatory, But Not Cardiovascular Biomarkers, in Patients Hospitalized for COVID-19.
    Myhre PL; Prebensen C; Jonassen CM; Berdal JE; Omland T
    J Am Heart Assoc; 2021 May; 10(9):e019756. PubMed ID: 33596668
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Examining the relationship between inflammatory biomarkers during COVID-19 hospitalization and subsequent long-COVID symptoms: A longitudinal and retrospective study.
    Sykes DL; Van der Feltz-Cornelis CM; Holdsworth L; Hart SP; O'Halloran J; Holding S; Crooks MG
    Immun Inflamm Dis; 2023 Oct; 11(10):e1052. PubMed ID: 37904690
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid responses to anakinra in patients with refractory adult-onset Still's disease.
    Fitzgerald AA; Leclercq SA; Yan A; Homik JE; Dinarello CA
    Arthritis Rheum; 2005 Jun; 52(6):1794-803. PubMed ID: 15934079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-inflammatory response of cardamom extract and prediction of therapeutic window in COVID-19 patients by assessing inflammatory markers using RT-PCR.
    Shakeeb N; Varkey P; Hynse A; Mandlecha A
    Inflammopharmacology; 2022 Jun; 30(3):883-894. PubMed ID: 35320494
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Prospective Effect of Allopurinol on the Oxidative Stress Index and Endothelial Dysfunction in Covid-19.
    Al-Kuraishy HM; Al-Gareeb AI; Al-Niemi MS; Aljowaie RM; Almutairi SM; Alexiou A; Batiha GE
    Inflammation; 2022 Aug; 45(4):1651-1667. PubMed ID: 35199285
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
    Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
    Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of Predictive Markers of Response to Immunomodulators in the Treatment of COVID-19 Patients.
    Caballero-Bermejo AF; Sancho-Lopez A; Ferrer-Armengou L; Jimenez-Martin ML; Fernandez-Cruz A; Ruiz-Antoran B
    Clin Lab; 2022 Sep; 68(9):. PubMed ID: 36125152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.